Acadia Healthcare Company Inc. Common Stock (ACHC) fair value

ACCE thesis

Acadia Healthcare operates behavioral health hospitals, residential treatment centers and outpatient clinics across the US and UK, and it is one of the few scaled owners of psychiatric beds in an area where demand has outrun supply for years. The moat is the hard part to replicate: licensed inpatient psychiatric capacity takes years to permit and staff, so incumbents keep pricing power that a general acute-care operator would not have. The near-term driver is margin repair rather than volume, with a 10.1% operating margin against a 41.1% gross margin leaving room for recovery if occupancy and payer mix improve. Revenue is currently shrinking slightly (-0.4%) and ROE sits at -41.4%, so the balance sheet and earnings quality need scrutiny before any upside case is credible. At a forward P/E of 15.2 the stock is priced below where a clean earnings recovery would put it, but the current score of 46/100 and the lack of index membership suggest the market is still discounting execution risk, which is what the deeper work should test.